A multicentre, randomised, double-blind, placebo-controlled trial to evaluate intravenous infusion of salbutamol versus saline for 28-day mortality in patients with acute respiratory distress syndrome

ISRCTN ISRCTN38366450
DOI https://doi.org/10.1186/ISRCTN38366450
Secondary identifying numbers Version 2
Submission date
14/04/2006
Registration date
07/07/2006
Last edited
16/09/2013
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Respiratory
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Fang Gao
Scientific

Adult Intensive Care Unit
Birmingham Heartlands Hospital
Bordesley Green East
Birmingham
B9 5SS
United Kingdom

Study information

Study designRandomised, double-blind, placebo-controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific title
Study acronymBALTI-2
Study objectivesIn patients with acute respiratory distress syndrome (ARDS), treatment with intravenous salbutamol will reduce 28-day mortality
Ethics approval(s)West Midlands Multicentre Research Ethics Committee, approval pending as of 01/05/2006
Health condition(s) or problem(s) studiedAcute respiratory distress syndrome
InterventionSalbutamol or placebo will be administered through a dedicated intravenous line for seven days
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)Salbutamol
Primary outcome measureMortality 28 days after randomisation
Secondary outcome measures1. Number of ventilator-free days
2. Mortality at (first) discharge from ICU
3. Mortality at discharge from hospital
4. Mortality at 12 months post randomisation
5. ICU length of stay
6. Hospital length of stay
7. Disability and quality of life at 12 months after randomisation
Overall study start date01/08/2006
Completion date01/09/2007

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants100
Key inclusion criteriaOn day 1 following intensive care unit (ICU) admission, the primary caring ICU clinician should consider all adult patients (age ≥18 years) with severe hypoxaemic respiratory failure (PaO2/FiO2) ≤26.7 kPa to be eligible for inclusion in the trial
Key exclusion criteria1. Pregnancy
2. Cardiogenic pulmonary oedema (confirmed by medical history and chest x-ray)
3. Severe obstructive airway disease requiring nebulised or intravenous (IV) beta 2-agonists
4. Treatment with beta 2-blockers ≤48 hours
5. Brain stem death
6. Treatment withdrawal ≤24 hours, which indicates any interventions (including a trial) would be considered inappropriate
7. Refusing consent or patients in whom relatives refuse assent
8. Enrolled in another interventional clinical trial in the last 28 days
Date of first enrolment01/08/2006
Date of final enrolment01/09/2007

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Adult Intensive Care Unit
Birmingham
B9 5SS
United Kingdom

Sponsor information

Heart of England NHS Foundation Trust (UK)
Hospital/treatment centre

Birmingham Heartlands Hospital
Bordesley Green East
Birmingham
B9 5SS
England
United Kingdom

Funders

Funder type

Research organisation

Intensive Care Society
Private sector organisation / Associations and societies (private and public)
Alternative name(s)
ICS
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article protocol 09/05/2011 Yes No
Results article results 21/01/2012 Yes No
Results article results 01/09/2013 Yes No